Skip to main content
Premium Trial:

Request an Annual Quote

Allegro Licenses Lung Cancer Testing IP from Boston University, University of Utah Foundation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Allegro Diagnostics today announced it has entered into an exclusive licensing deal with Boston University and the University of Utah Foundation for intellectual property related to Allegro's molecular testing platform used to detect early signs of lung cancer.

Financial and other terms of the deal were not disclosed.

Allegro's platform uses gene expression technology and detects common molecular responses that occur throughout the respiratory tract in current and former smokers with lung cancer. These changes can be detected in a gene expression signature from non-malignant airway cells and indicate the presence of malignancy remotely in the lung, Allegro said.

Using its platform, Allegro has generated "multiple product candidates." Its first commercially available test is expected to be the BronchoGen genomic test, which could potentially be incorporated into standard bronchoscopy procedures for additional clinical information and to support rapid diagnosis and treatment.

The deal will support advancement of the Maynard, Mass.-based company's platform, including the launch of the BronchoGen test during the first half of 2012, Mike Webb, the newly appointed president and CEO of Allegro, said in a statement.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.